GGrantIndex
Sort

16,300 grants matching fatty liver disease

Neuregulin-4 Signaling in Hepatocytes Defines an Endocrine Checkpoint for NASH and HCC Progression

$41,071
Henry Kuang · University Of Michigan At Ann Arbor · F30 · FY2020 · DK

The role of AEG-1 in NASH and NASH-HCC

$41,044
Devanand Sarkar · Virginia Commonwealth University · R01 · FY2025 · DK

Exercise, mitochondrial function, and fatty acid oxidation in fatty liver disease

$41,024
Randy Scott Rector · University Of Missouri-Columbia · F32 · FY2009 · DK

Lysosome and integrated stress response in aging and alcohol-associated liver disease

$41,024
Sha Neisha Williams · University Of Kansas Medical Center · F31 · FY2025 · AA

Elucidating the Mechanisms of Lipid Droplet Protein Degradation

$40,987
Melissa Roberts · University Of California Berkeley · F31 · FY2020 · DK

Synergy of lipolysis and lipophagy in alcoholic liver disease

$40,986
Micah Schott · Mayo Clinic Rochester · K99 · FY2021 · AA

THE NATURAL HISTORY OF NONALCOHOLIC FATTY LIVER DISEASE

$40,958
Arun J Sanyal · Virginia Commonwealth University · M01 · FY2008 · RR

The Role of Apolipoprotein A-V in Chylomicron Metabolism

$40,911
Xenia Danae Davis · University Of Cincinnati · F31 · FY2022 · DK

The Mechanism of Cetp-Mediated Protection from High-Fat Diet-Induced Insulin Resistance

$40,861
Brian T. Palmisano · Vanderbilt University · F30 · FY2015 · DK

Targeting Gut Microbiota Metabolites to Prevent Liver Cancer

$40,854
Rachel M. Golonka · University Of Toledo Health Sci Campus · F31 · FY2022 · CA

Alcohol and calorie-dense diet-mediated hepatic mitochondrial dysregulation

$40,827
Eden McMillin Gallegos · Lsu Health Sciences Center · F30 · FY2024 · AA

Mechanisms of adipocyte loss in mouse models of familial partial lipodystrophy 2

$40,819
Jessica Nanda Maung · University Of Michigan At Ann Arbor · F31 · FY2023 · DK

MiR-33 and Aging: Implications for Metabolic Syndrome

$40,764
Leigh Goedeke · New York University School Of Medicine · F31 · FY2014 · AG

NON-ALCOHOLIC STEATOHEPATITIS CLINICAL RESEARCH NETWORK

$40,698
Joel Edward Lavine · University Of California, San Diego · M01 · FY2007 · RR

Increasing muscle mass resolves vascular dysfunction in obesity

$40,677
Andrew Speese · Augusta University · F31 · FY2025 · HL

Summer Endocrine Research Training Program

$40,654
Carolyn M. Klinge · University Of Louisville · T35 · FY2024 · DK

Mechanism of Intracellular ANGPTL3 and ANGPTL8 Trafficking

$40,628
Christina So · Univ Of North Carolina Chapel Hill · F31 · FY2025 · HL

Summer Endocrine Research Training Program

$40,621
Carolyn M. Klinge · University Of Louisville · T35 · FY2018 · DK

The role of mitochondrial ATP production in liver failure

$40,613
Cameron Joseph Menezes · Ut Southwestern Medical Center · F30 · FY2025 · DK

Neuregulin-4 Signaling in Hepatocytes Defines an Endocrine Checkpoint for NASH and HCC Progression

$40,567
Henry Kuang · University Of Michigan At Ann Arbor · F30 · FY2019 · DK

Dissecting the tissue-specific role of the NADP(H) phosphatase, Nocturnin

$40,523
Lauren Palluth · Ut Southwestern Medical Center · F31 · FY2025 · DK

Regulation of SREBP-1 Processing Lipogenesis by LPCAT

$40,483
Bo Wang · University Of California Los Angeles · F32 · FY2017 · DK

Elucidating the Mechanisms of Lipid Droplet Protein Degradation

$40,483
Melissa Roberts · University Of California Berkeley · F31 · FY2019 · DK

Lysosome and integrated stress response in aging and alcohol-associated liver disease

$40,460
Sha Neisha Williams · University Of Kansas Medical Center · F31 · FY2024 · AA

Investigating folliculin as a regulator of VLDL-TG secretion in non-alcoholic fatty liver disease and steatohepatitis

$40,360
Chelsea Thorsheim · University Of Pennsylvania · F31 · FY2025 · DK